- Report
- December 2024
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- May 2025
- 150 Pages
Global
From €2416EUR$2,699USD£2,058GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1119EUR$1,250USD£953GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1343EUR$1,500USD£1,144GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1119EUR$1,250USD£953GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1119EUR$1,250USD£953GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1119EUR$1,250USD£953GBP
- Report
- April 2025
- 185 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- January 2025
- 180 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- May 2025
- 112 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- January 2025
- 210 Pages
Global
From €4472EUR$4,995USD£3,809GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2229EUR$2,490USD£1,899GBP
- Report
- November 2021
- 295 Pages
Global
From €4924EUR$5,500USD£4,194GBP
- Report
- May 2023
- 143 Pages
Global
From €2014EUR$2,250USD£1,716GBP
- Report
- March 2025
- 200 Pages
India
From €2229EUR$2,490USD£1,899GBP
- Report
- May 2024
- 134 Pages
Global
From €5818EUR$6,499USD£4,956GBP

Amphotericin B is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. It is commonly used to treat systemic fungal infections, such as those affecting the lungs, heart, and central nervous system. It is also used to treat fungal infections of the skin, nails, and eyes. Amphotericin B is a polyene macrolide antibiotic, and is the most commonly used antifungal drug in the world. It is available in both intravenous and oral formulations, and is often used in combination with other antifungal drugs.
The Amphotericin B market is a subset of the larger Infectious Diseases Drugs market. It is a highly competitive market, with a number of companies offering Amphotericin B products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more